The trial will inform whether detection of ventricular arrhythmias by means of implantable loop recorder (ILR) can help to predict SCD in the large population of survivors of a myocardial infarction with preserved left ventricular function, EF\>40%. This may improve risk stratification in these patients, and can inform on the clinical use of subcutaneous monitors to identify post-infarction populations in need for an intervention to prevent sudden death.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
50
State Research Institute of CIrculation Pathology Novosibirsk, Russian Federation
Novosibirsk, Russia
Cardiac arrest
Time frame: 24 months
Sustained, nonsustained, symptomatic, asymptomatic ventricular tachycardias
Time frame: 24 months
Ventricular fibrillation
Time frame: 24 months
Atrial Fibrillation (symptomatic and asymptomatic)
Time frame: 24 months
Documented Arrhythmic death without evidence of primary non cardiac cause
Time frame: 24 months
All Arrhythmic events recorded by ILR
Time frame: 24 months
Changing in treatment strategy, based on physician decision
Time frame: 24 months
Invasive procedures for arrhythmia treatment
Time frame: 24 months
Changing in medical treatment (anticoagulation, antiarrhythmic drugs)
Time frame: 24 months
CV events
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.